GlassScriptPhysician profile
Fitzclarence Harper
NPI 1962433508
$7,101.56
in general payments reported to CMS, 2019-2025
25 companies · $3,451 in 2025
The $3,451 reported for 2025 was more than what 87% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $121 · 2021: $371 · 2022: $74.13 · 2023: $1,358 · 2024: $1,403 · 2025: $3,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $1,876 · Travel and Lodging: $1,145 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $1,876.01 |
| Travel and Lodging | $1,144.77 |
| Education | $191.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elliquence, LLC | $3,000.00 | 2025 | |
| Medtronic, INC. | $1,272.79 | 2021-2024 | Synchromedii, Kyphon Express II Kyphopak Tray |
| Curonix LLC | $986.26 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $376.80 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $294.65 | 2023-2025 | Belbuca, Xtampza, Nucynta |
| Electronic Waveform Lab, INC. | $227.54 | 2019-2025 | |
| Smith+Nephew, INC. | $203.62 | 2023 | Goflo Pump, Lens 4k, Lens |
| Zynex Medical, INC. | $145.25 | 2023 | Nexwave |
| Horizon Therapeutics Plc | $106.41 | 2019-2021 | |
| Forte Bio-Pharma LLC | $74.13 | 2022 | |
| Spr Therapeutics, INC | $68.00 | 2023 | Sprint Pns System |
| Stimwave Technologies Incorporated | $51.00 | 2021 | |
| Indivior INC. | $42.42 | 2019 | |
| Boston Scientific Corporation | $40.08 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $36.83 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $25.00 | 2025 | |
| Camber Spine Technologies LLC | $23.48 | 2021 | |
| Almatica Pharma LLC | $19.42 | 2021 | |
| Nevro Corp. | $18.15 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.46 | 2023 | Relistor |
| Astrazeneca Pharmaceuticals LP | $16.88 | 2019 | |
| Biodelivery Sciences International, INC. | $15.36 | 2019 | |
| Biotronik Nro, INC. | $14.79 | 2024 | Prospera |
| Teva Pharmaceuticals USA, INC. | $13.55 | 2019 | |
| Fidia Pharma USA INC. | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fitzclarence Harper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.